Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #01, April 2016
A Missouri federal court has reset a talcum powder ovarian cancer lawsuit for trial in July, asking the parties to file in limine motions 10 days before the new trial date.
Jurors have awarded $72 million at the conclusion of a talcum powder exposure suit filed by the family of a woman who said that 35 years of using the product caused her to develop ovarian cancer.
A Missouri federal court overseeing a talc powder ovarian cancer case has struck causation testimony from a plaintiff expert, ruling that he was not properly disclosed as an expert witness testifying on causation.
Imerys Talc America Backs Motion for Summary Judgment, Says it Only Supplied ‘Fundamentally Safe Raw Mineral’
Imerys Talc America Inc. has backed its motion for summary judgment, saying that it is not the manufacturer of the finished product to which the plaintiffs alleged exposure.
An Illinois federal court overseeing a talc-based powder class action lawsuit has granted Johnson & Johnson’s motion to dismiss the complaint for failure to state a claim, but granted the plaintiff leave to amend.
A defendant named in a talc-related ovarian cancer suit has moved for summary judgment and to exclude the testimony of a plaintiff’s expert, saying in part that the expert has never published the conclusion that talc can cause ovarian cancer.
A multi-county litigation designation has been assigned to claims involving talc-based body powder products used for feminine hygiene purposes, according to a recent notice.